ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 26 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,747 | -45.3% | 4,501 | -25.0% | 0.00% | – |
Q2 2023 | $21,482 | +140.3% | 6,001 | +46.4% | 0.00% | – |
Q1 2023 | $8,938 | -98.9% | 4,100 | -93.7% | 0.00% | – |
Q4 2022 | $778,124 | +102.6% | 64,682 | +9.0% | 0.00% | – |
Q3 2022 | $384,000 | +1376.9% | 59,332 | +964.1% | 0.00% | – |
Q2 2022 | $26,000 | -97.7% | 5,576 | -95.7% | 0.00% | – |
Q1 2022 | $1,116,000 | -14.1% | 129,061 | +41.9% | 0.00% | – |
Q4 2021 | $1,299,000 | +576.6% | 90,962 | +939.7% | 0.00% | – |
Q3 2021 | $192,000 | +170.4% | 8,749 | +66.1% | 0.00% | – |
Q2 2021 | $71,000 | +108.8% | 5,267 | +57.2% | 0.00% | – |
Q1 2021 | $34,000 | +183.3% | 3,350 | +17.5% | 0.00% | – |
Q4 2020 | $12,000 | +71.4% | 2,850 | 0.0% | 0.00% | – |
Q3 2020 | $7,000 | -56.2% | 2,850 | -35.6% | 0.00% | – |
Q2 2020 | $16,000 | +33.3% | 4,425 | +14.9% | 0.00% | – |
Q1 2020 | $12,000 | -7.7% | 3,850 | +48.1% | 0.00% | – |
Q4 2019 | $13,000 | -18.8% | 2,600 | -47.5% | 0.00% | – |
Q3 2019 | $16,000 | -11.1% | 4,950 | 0.0% | 0.00% | – |
Q2 2019 | $18,000 | -51.4% | 4,950 | -51.5% | 0.00% | – |
Q1 2019 | $37,000 | +19.4% | 10,200 | 0.0% | 0.00% | – |
Q4 2018 | $31,000 | -45.6% | 10,200 | -12.8% | 0.00% | – |
Q3 2018 | $57,000 | -28.8% | 11,700 | +9.3% | 0.00% | – |
Q2 2018 | $80,000 | +50.9% | 10,700 | +32.1% | 0.00% | – |
Q1 2018 | $53,000 | -43.6% | 8,100 | -22.5% | 0.00% | – |
Q4 2017 | $94,000 | -35.6% | 10,450 | -29.0% | 0.00% | – |
Q3 2017 | $146,000 | +28.1% | 14,725 | 0.0% | 0.00% | – |
Q2 2017 | $114,000 | +32.6% | 14,725 | +4.4% | 0.00% | – |
Q1 2017 | $86,000 | +75.5% | 14,100 | +76.2% | 0.00% | – |
Q4 2016 | $49,000 | -15.5% | 8,000 | 0.0% | 0.00% | – |
Q3 2016 | $58,000 | -18.3% | 8,000 | -5.9% | 0.00% | – |
Q2 2016 | $71,000 | +6.0% | 8,500 | -15.6% | 0.00% | – |
Q1 2016 | $67,000 | -24.7% | 10,075 | -2.4% | 0.00% | – |
Q4 2015 | $89,000 | +58.9% | 10,325 | 0.0% | 0.00% | – |
Q3 2015 | $56,000 | +47.4% | 10,325 | +58.8% | 0.00% | – |
Q2 2015 | $38,000 | +171.4% | 6,500 | +188.9% | 0.00% | – |
Q1 2015 | $14,000 | – | 2,250 | +2150.0% | 0.00% | – |
Q4 2014 | $0 | -100.0% | 100 | -75.0% | 0.00% | – |
Q2 2014 | $4,000 | -73.3% | 400 | -67.6% | 0.00% | – |
Q1 2014 | $15,000 | -28.6% | 1,234 | -7.5% | 0.00% | – |
Q4 2013 | $21,000 | +162.5% | 1,334 | 0.0% | 0.00% | – |
Q3 2013 | $8,000 | -27.3% | 1,334 | -1.8% | 0.00% | – |
Q2 2013 | $11,000 | – | 1,358 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |